COVID Updates: Where We Are and Where We Go From Here
We invite you to learn more about:
- New and emerging therapies to treat myeloma
- CAR T-cell therapy for myeloma
- Side effect management
- How to discuss quality of life issues with your doctor
Craig Emmitt Cole, MD
Assistant Professor, Division of Hematology
and Oncology
Michigan State University College of Human
Medicine
Karmanos Cancer Institute at McLaren
Greater Lansing
Lansing, MI
Program Support
Support for this program is provided by Bristol Myers Squibb, GSK, and Karyopharm Therapeutics.